Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).
about
Management of gastric polyps: an endoscopy-based approachIs there something other than imatinib mesilate in therapeutic options for GIST?Adjuvant treatment of GIST: patient selection and treatment strategies.Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST).Adjuvant therapy for high-risk gastrointestinal stromal tumour: considerations for optimal management.The role of adjuvant and neoadjuvant therapy in gastrointestinal stromal tumors.Imatinib as the first and only treatment in Europe for adult patients at significant risk of relapse following gastrointestinal stromal tumor removal.Case Report: Jejunal gastrointestinal stromal tumour, a rare tumour, with a challenging diagnosis and a successful treatment.Approval summary: imatinib mesylate in the adjuvant treatment of malignant gastrointestinal stromal tumors.Imatinib mesylate: past successes and future challenges in the treatment of gastrointestinal stromal tumors.Gastrointestinal Stromal Tumors (GIST): A Prospective Analysis and an Update on Biomarkers and Current Treatment Concepts.The efficacy of adjuvant imatinib therapy in improving the prognosis of patients with colorectal gastrointestinal stromal tumours.The inside mystery of jejunal gastrointestinal stromal tumor: a rare case report and review of the literatureTyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ.Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumorsManagement of gastrointestinal stromal tumours in the Imatinib era: a surgeon's perspectiveImpact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutationsImatinib treatment for gastrointestinal stromal tumour (GIST).Targeted cancer therapies in the twenty-first century: lessons from imatinib.Imatinib mesylate for the treatment of gastrointestinal stromal tumor.Navigating risk stratification systems for the management of patients with GIST.Adjuvant imatinib for gastrointestinal stromal tumors: the current situation and problems.Current and emerging pharmacological treatments for gastrointestinal stromal tumour.Imatinib as adjuvant therapy for gastrointestinal stromal tumors: a systematic review.Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors.Adjuvant imatinib therapy for gastrointestinal stromal tumors.Optimized dose of imatinib for treatment of gastrointestinal stromal tumors: a meta-analysis.Comparison of different adjuvant therapies for 9 resectable cancer types.Managing GIST in the imatinib era: optimization of adjuvant therapy.Small Intestinal and Mesenteric Multiple Gastrointestinal Stromal Tumors Causing Occult BleedingA hidden source for upper gastrointestinal bleeding.Extragastrointestinal stromal tumor originating from the vulva.The Scandinavian Sarcoma Group: 30 years' experience.Giant GIST of the stomach: a successful case of safe resection with preoperative simulation using three-dimensional CT angiography: Case report.An infrequent case of intussusception caused by gastrointestinal stromal tumor in an adult patient.ULTRASONOGRAPHIC FEATURES OF CANINE GASTROINTESTINAL STROMAL TUMORS COMPARED TO OTHER GASTROINTESTINAL SPINDLE CELL TUMORS
P2860
Q26864650-F7C29F2D-3076-4C43-9416-D3347BC5AA1AQ34207379-8453DAB4-02FC-483A-B90F-62624D4D88AFQ34270274-8D336FAB-E8F3-4C5F-869D-45CDF8303F91Q34276167-ED8B4F88-379A-4F07-9FDF-ECE4DC4D94EEQ34300784-5251B65C-22D7-4687-98CC-393BE59A328DQ34359712-34C7E54F-57F4-448F-8F72-F2E254BC9ADCQ35026332-479CDAF4-0D4E-4D93-A6C1-AF1AAED7D5E4Q35561995-CE109B02-E2DD-4DA4-ACEE-959AFBAA76F3Q35583962-65953DE1-508F-476F-9F2D-37C0B9F2C8C6Q35607790-CE8BA58D-FEE6-4B1A-94D7-DDC467107DFBQ35679349-4FF7E57B-9D9D-46FA-BB18-E9AD7A64D87DQ35759790-AD81EA72-B153-47D5-BC85-DB5FE3B13F0AQ35953066-FBA05422-152C-48F6-A91D-E92A6AEF1CD4Q36162943-59F5BF60-B5C0-4071-9A94-CEF62010968CQ36572499-EF67BBAC-3641-4002-838A-5B0B4C5E13C8Q36800837-D39DA385-BCD2-4FA1-BE3E-DE2A45A4EAFFQ37186795-6A62426E-6B6D-4721-AF18-DD974C2BC72EQ37334993-C1078D51-A896-4285-A459-578FF8F15D9DQ37710963-122B194F-692E-4F9B-A264-94683A8CA121Q37752353-B3B29E31-513F-4695-B883-F47E467C009CQ37826657-3D7C2344-D702-4D13-8782-7456892AE173Q37832738-D0FDCAE7-835F-4C4D-86B0-4FF3A27C5707Q37841551-E9114167-3CFD-46B2-AA2D-D92611CA7438Q37851064-C62E63BE-3482-4CA7-9640-C3EA1246F628Q37889247-F2E79623-D00D-4C67-940A-D4EA1CBBE8D1Q37954206-7EF126A6-8460-425A-AB86-CC29379A2591Q38057419-E8AE5749-E1BC-4D73-8015-52B99BDD9BC1Q38118480-D8126834-5CB8-4411-A830-9596BCB44846Q38262193-AD28D30A-11DA-4451-963B-3EE7F5F81B12Q38686060-7EFC2EEA-CE3E-4D11-95AC-1B4572F609A5Q38806062-EEEE9CEB-896E-4B97-9B65-69488C57469BQ42246420-38023856-E064-4AB9-888B-770F99AB33C4Q43589203-CF937178-6FB2-43A4-86BD-1403A188F7CEQ50003108-27AF4328-436E-47D6-B2F2-35C00D69F4CEQ55469953-97406254-8A9D-4447-AF7D-64E2F46BEE8AQ57812383-00D4A6CA-F7C8-436D-8F05-8541858DA233
P2860
Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Adjuvant imatinib treatment im ...... stinal stromal tumours (GIST).
@ast
Adjuvant imatinib treatment im ...... stinal stromal tumours (GIST).
@en
type
label
Adjuvant imatinib treatment im ...... stinal stromal tumours (GIST).
@ast
Adjuvant imatinib treatment im ...... stinal stromal tumours (GIST).
@en
prefLabel
Adjuvant imatinib treatment im ...... stinal stromal tumours (GIST).
@ast
Adjuvant imatinib treatment im ...... stinal stromal tumours (GIST).
@en
P2093
P2860
P356
P1476
Adjuvant imatinib treatment im ...... stinal stromal tumours (GIST).
@en
P2093
Andersson J
Kindblom LG
Meis-Kindblom JM
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603797
P407
P50
P577
2007-05-29T00:00:00Z
P5875
P6179
1021298830